Neudle.com: multiple sclerosis MRI criteria

Differential
(Click to cross reference)

abscess, intracerebral

abscess, intracranial-fungal

abscess, lung

acute disseminated encephalomyelitis

acute disseminated encephalomyelitis, multiphasic

acute disseminated encephalomyelitis, relapsing

acyclovir

Addison's disease

adrenoleukodystrophy

adrenoleukodystrophy, adult onset

adrenoleukodystrophy, carrier

advances in neurology

adverse drug reaction

afebrile

algorithm

alveolar hypoventilation

Alzheimer's disease

Alzheimer's disease, diagnosis of

Alzheimer's disease, preclinical

amyloid angiopathy, cerebral

amyloid plaques

amyotrophic lateral sclerosis

ANA

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiography, cerebral

angiography, cerebral, false negative

angiography, cerebral, negative

angiography, spinal

angiotensin-converting enzyme

anti MAG antibodies

anti Ro antibody

antibiotics

antibodies to myelin basic protein

antimyelin antibodies

antineutrophil cytoplasmic autoantibodies

antiviral agents

aphasia

area postrema

area postrema syndrome

attention deficit disorder with hyperactivity

autonomic dysfunction

Babinski sign

bacterial infection

Barkhof MR criteria for MS

basal ganglia

basal ganglia, lesion of

bone marrow transplantation

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

brainstem

brainstem, lesion of

brucellosis, nervous system involvement with

Brudzinski's sign

calcification, intracranial

calcium antagonist

Call-Fleming syndrome

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, double dose

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

caudate nucleus

caudate nucleus, atrophy

central nervous system, infection of

central vein sign

cerebellar lesion

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral edema

cerebral edema, vasogenic

cerebral infarction

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal bands, absent

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, proteincytologic dissociation

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, bilateral

cerebrovascular accident, familial occurrence

cerebrovascular accident, infancy and childhood

cerebrovascular accident, mimics

cerebrovascular accident, multiple

cerebrovascular accident, women

cerebrovascular accident, young adult

chest x-ray

chest x-ray, abnormal

children

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

coma

complications

confusion

conjugate gaze, forced

controversies in neurology

conversion reaction

cop 1

corpus callosum

corpus callosum, lesion of

cortical blindness

cost

cranial nerve palsies

cranial neuropathy

crying, pathologic

cryptococcoma, cerebral

degenerative diseases of CNS

delay in diagnosis

dementia

dementia, diagnostic evaluation of

dementia, early detection

dementia, frontotemporal

dementia, rapidly progressive

dementia, screening for

dementia, subcortical

demyelinating disease

dentate nuclei

dentate nuclei, lesion of

diagnostic criteria

diarrhea

diencephalon

differential diagnosis

diplopia

disability, neurological

disorientation

Dot-Dash sign

drug induced neurologic disorders

dura, thickened

dysarthria

dysarthria-clumsy hand syndrome

electroencephalogram, abnormalities of

electroencephalogram, focal delta activity

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, focal

encephalitis, paraneoplastic

encephalitis, Rasmussen's

encephalitis, recurrent

encephalitis, viral

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

enterovirus

epidemiology of neurology

episodic disorders

episodic neurologic deficits

Epstein-Barr virus

evoked potentials

extinction on double simultaneous stimulation

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

flaccid paralysis

flu-like illness

fluorescein angiography

fourth ventricle, floor

fundus, abnormality of

funduscopic exam

fungal infection

fungal infection, CNS

gadolinium

gait disorder

gallium scan

gammaglobulin therapy, intravenous

genetic diagnosis, prenatal

genetic linkage

genetic neurologic disorders

granulomatosis with polyangiitis

headache, thunderclap

hearing loss

hearing loss, bilateral

hearing loss, sudden, bilateral

hemiparesis

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, diagnosis of

herpes simplex encephalitis, prognosis of

herpes simplex encephalitis, treatment of

herpes simplex virus

herpes virus

hiccoughs

hiccoughs, intractable

hydrocephalus, exvacuo

hydrocephalus, normal pressure

hyperreflexia

hypersomnia

hypertrophic intracranial pachymeningitis

hypertrophic pachymeningitis, IgG4 related disease

hypoglycorrhachia

hyponatremia

hypothalamus

hypothalamus, damage to

hypothalamus, lesion of

iatrogenic neurologic disorders

IgG4-related disease

immune reconstitution inflammatory syndrome

immunization, neurologic complications with

immunohistochemistry

immunologic disease

immunomodulation

immunosuppressive agents

immunotherapy

in situ hybridization

inappropriate antidiuretic(A.D.H.)hormone

infection

intellectual deterioration

interferon

interferon antibodies

interferon beta 1-a

interferon beta 1-b

intracerebral hemorrhage

intracerebral hemorrhage, lobar

iron, brain

Jakob-Creutzfeldt disease

Kernig's sign

laughing, pathologic

leg weakness, bilateral

Leigh's disease

lenticular nucleus, lesion of, bilateral

level of consciousness, decreased

Lewy body disease, diffuse

lymphoma involving CNS

magnetic stimulation

magnetic stimulation, brain

magnetic susceptibility

magnetic transfer imaging

MAGNIMS group

malformation, vascular

malformation, vascular, cerebral

malignancy screen

maple syrup urine disease

McDonald criteria for MS

medulla oblongata

medulla oblongata, lesion of

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis

meningitis, granulomatous

mental status, abnormal

meralgia paresthetica

mesial temporal sclerosis

metronidazole

microangiopathy, brain

microangiopathy, retina

microhemorrhage, intracerebral

migraine

mimics

misdiagnosis

monoclonal antibodies

monoclonal gammopathy

MRI, angiography, false negative

MRI, CAT scan compared to

MRI, complications with

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, disappearing lesion on

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, FLAIR

MRI, flow void, blood

MRI, functional

MRI, high signal foci on

MRI, incidental finding

MRI, indications for

MRI, lesion burden

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, optic nerve

MRI, paramagnetic effect

MRI, snowball lesions

MRI, spinal cord

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

MRI, volumetry

MRI, voxel-based morphometry

MRS

multinucleated giant cell

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, clinically isolated syndrome

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, late-onset

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, tumefactive

multiple sclerosis, without CSF bands

multiple sclerosis, work up for

multiple system atrophy

myelitis, longitudinal

myelitis, post infectious

myelitis, transverse

myelitis, transverse, idiopathic

myelitis, transverse, recurrent

myelopathy, ascending

myelopathy, chronic progressive

neoplasm, primary intracerebral

neoplasm, primary of CNS

neuroendocrinology

neurofibrillary degeneration

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuromyelitis optica (Devic's disease), screening

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

old age, neurology of

optic atrophy

optic chiasm

optic chiasm, lesion of

optic nerve

optic nerve, lesion of

optic neuritis

optic neuritis, alternating

optic neuritis, bilateral

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

optic neuropathy

optical coherence tomography

organomegaly

ovarian tumor

oxybutynin

pachymeningitis, cranial

paralysis, acute areflexic

paramagnetic rim lesion, MR

patient information and support

periaqueductal lesion

perihippocampal fissure

perineum, numbness of

pleocytosis of cerebrospinal fluid

POEMS syndrome

poliomyelitis-like illness

polymerase chain reaction

polymerase chain reaction, false negative

port wine nevus

posterior fossa

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

potassium channel antibodies

practice guidelines

precipitating factors

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive supranuclear palsy

pseudobulbar palsy

pseudotumor

psychiatric disorder

psychiatric problems in neurologic disorders

putamen, lesion of

pyramidal tract

pyramidal tract dysfunction

rapidly progressing neurologic illness

recurrent

Red flags

rehabilitation for neurologic disorders

remission

remote effect of cancer on the nervous system

renal failure

respiratory failure

retinal artery occlusion

retinal branch artery occlusion

retinal infarction

retinopathy

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

risk factors

rituximab

saccadic eye movements, abnormal

sarcoidosis

sarcoidosis, CNS

scleroderma, neurologic involvement with

screening

sedimentation rate, elevated

seizure, psychomotor-temporal lobe

sensorineural hearing loss

sensory loss

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

seronegative

single photon emission computed tomography

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

spinal cord, compression of

spinal cord, enlargement

spinal cord, lesion of

spinal cord, vascular malformation of

splenium of corpus callosum

status epilepticus

steroid

steroid therapy, CNS treatment and complications with

strokelike episodes

Sturge-Weber syndrome

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subacute sclerosing panencephalitis, adult onset

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

Susac's syndrome

sweet taste

symmetric brain lesions

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tau protein

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

thyroiditis

tinnitus

tongue, impaired movements of

tonic spasms

toxic encephalopathy

tractography

transient neurologic deficit

treatment of neurologic disorder

tuberculin skin test, positive

vaccination, neurologic complications with

vaccine

vascular malformation, children, intracranial

vasculopathy

vasoconstrictive drugs

vasospasm

vasospasm, cerebral

ventricular enlargement

vertigo

very long chain fatty acids

viral infection

viral infection, CNS

vision loss, sequential

visual evoked response

visual field defect

visual loss

visual loss, progressive

visual loss, sudden

visual symptoms

vomiting, intractable

walking, difficulty with

water channel antibodies

Showing articles 250 to 300 of 10329 << Previous Next >>

Tumefactive MS Lesions under Fingolimod
Neurol 81:1654-1658, Pilz, G.,et al, 2013

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Subacute Sclerosing Panencephalitis
www.MedLink.com, February, Auwaeter,P.G.&Johnson,R.T., 2013

Extensive Vasogenic Edema of Anti-Aquaporin-4 Antibody-Related Brain Lesions
Mult Scler 15:1113-1117, Matsushita, T.,et al, 2013

Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

The Thalamus and Multiple Sclerosis
Neurol 80:210-219, Minagar, A.,et al, 2013

Central Nervous System Lymphoma Initial Diagnosed as Tumefective Multiple Sclerosis after Brian Biopsy
Intern Med 52:483-488, Ohe, Y.,et al, 2013

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balos Concentric Lesions
Intern Med 52:1517-1521, Masuda, H.,et al, 2013

Brain Atrophy is Related to Lacunar Lesions and Tissue Microstructural Changes in CADASIL
Stroke 38:1786-1790, Jouvent, E.,et al, 2012

Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis
Arch Neurol 69:1259-1269, Radue, E.W.,et al, 2012

Monosymptomatic Clinically Isolated Syndrome with Sudden Sensorineural Hearing Loss
The Neurologist 18:302-305, Anagnostouli, M.C.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012

Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Should we be nervous about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurologic opinion
JNNP 83:1216-1221, Currie, S.,et al, 2012

Cerebral Amyloid Angiopathy
eMedicine, Jan, Menon, R.S., 2012

Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012

Recovery after Spinal Cord Infarcts
Neurol 78:114-121, Robertson,C.E.,et al, 2012

Assessing Abnormal Iron Content in the Deep Gray Matter of Patients with Multiple Sclerosis verus Healthy Controls
AJNR 33:252258, Habib,C.A.,et al, 2012

Solitary Sclerosis
Neurol 78:540-544, Schmalstieg,W.F.,et al, 2012

Serologic Diagnosis of NMO
Neurol 78:665-671, Waters,P.J.,et al, 2012

Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions
Neurol 78:1655-1662, Abou Zeid, N.,et al, 2012

"Undiagnosing" Multiple Sclerosis
Neurol 78:1986-1991,1904, Solomon, A.J.,et al, 2012

Current Concept of Neuromyelitis Optica (NMO) and NMO Spectrum Disorders
JNNP doi:10.1136/JNNP-2012-302310, Jacob, A.,et al, 2012

The Differential Diagnosis of Longitudinally Extensive Transverse Myelitis
Mult Scler 18:271-285, Kitley, J.L.,et al, 2012

Inflammatory Cortical Demyelination in Early Sclerosis
NEJM 365:2188-2197, Lucchinetti, C.F.,et al, 2011

A Strange Case of Waitress Headache
Lancet 378:1824, Libera, D.D.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011

Clinical and Functional Outcome and Factors Predicting Prognosis in Osmotic Demyelination Syndrome (Central Pontine and/or Extrapontine Myelinolysis) in 25 Patients
JNNP 82:326-331, Kallakatta,R.N.,et al, 2011

Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
Neurol 76:1858-1865, OConnor, P.W.,et al, 2011

Paraneoplastic isolated myelopathy Clinical course and neuroimaging clues
Neurol 76:2089-2095, Flanagan, E.P.,et al, 2011

Sustained motion perception deficit following optic neuritis Behavioral and cortical evidence
Neurol 76:2103-2111, Raz, N.,et al, 2011

N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Arch Neurol 68:1069-1072, Smith, J.H.,et al, 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Balos Concentric Sclerosis
NEJM 365:742, Wengert, O.,et al, 2011

Longitudinal Change of Biomakers in Cognitive Decline
Arch Neurol 68:1257-1266,1237, Lo, R.Y.,et al, 2011

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
NEJM 365:1293-1303, OConnor, P.,et al, 2011

Asymptomatic Spinal Cord Lesions Predict Disease Progression in Radiologically Isolated Syndrome
Neurol 76:686-692, 680, Okuda,D.T.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Dysexecutive Syndrome: Diagnostic Criteria and Validation Study
Ann Neurol 68:855-864, Godefroy,O.,et al, 2010

Diagnostic Role of Target Lesion on Diffusion-WEighted Imaging, A Case of Cerebral Aspergillosis and Review of the Literature
Neurologist 16:364-367, Finelli,P.F.,et al, 2010

Cerebral Amyloid Angiopathy
UpToDate: May 2010, Greenberg,S.M.,et al, 2010

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Showing articles 250 to 300 of 10329 << Previous Next >>